Connor S. Centner, Ph.D.

SIO '26 Young Investigator
Creating the next generation of biodevices and biomedicines

[Connor S. Centner, Ph.D. @ConnorCentner]

It was great to present our next-generation histotripsy technology at the @UofLBCC research retreat. Thank you @KosairForKids for supporting our research to advance new treatments for pediatric cancer.

[Connor S. Centner, Ph.D. @ConnorCentner]

Grateful to receive a SBIR/STTR Micro-Award from @KSEF_Team. This support is helping us advance our work on histotripsy for targeted tumor ablation and immune activation. We’ll be using the funds to generate key preliminary data as we prepare for an upcoming NIH SBIR submission.

[Radiology @radiology_rsna]

Is ablation redefining liver tumor care? See advantages over resection and expanding roles for thermal & nonthermal techniques combined with systemic therapy, immunotherapy & AI guidance @ConnorCentner @GeorgiadesMD @MarkYarchoan @DrCliffWeiss @Hopkins_Rad https://t.co/anqVn2V1Y2

[SIO @SIO_Central]

Celebrating emerging leaders in IO at #SIOSavannah! 🎉
Honored to recognize this year’s Young IO Research Award recipients — Connor Centner, PhD, MD Candidate (University of Louisville) and Yungpeng Yang (UCSD)

[Connor S. Centner, Ph.D. @ConnorCentner]

Tremendously honored to receive the @SIO_Central Young Interventional Oncologist Research Award at #SIO2026. Thankful for the mentors and collaborators who made this possible.

[Connor S. Centner, Ph.D. @ConnorCentner]

@Dr_Robertson_MD Great work @Dr_Robertson_MD

[Nicole Robertson MD, MPH @Dr_Robertson_MD]

Hot off the press @journal_CHEST: Our review and meta-analysis unpacks the prevalence, risk factors, and outcomes of Preserved Ratio Impaired Spirometry. Global prevalence of PRISm was 12% with greater prevalence in LMICs. PRISm was associated with increased risk of mortality.

[Radiology @radiology_rsna]

OpenAI’s GPT-4 could detect and revise errors in head CT reports, demonstrating its feasibility as a tool for proofreading radiology reports. https://t.co/CZoFfjdgKe

[Acoustical Society of America @acousticsorg]

#ASA Lay Language Paper

Tiny but powerful: a new miniature histotripsy device is using sound waves to shatter cancer cells from the inside out! Imagine targeted, non-invasive cancer treatment that doesn’t need surgery. https://t.co/Li5W1RweW0

#CancerResearch @ConnorCentner

[UofL Med School @uoflmedschool]

Congrats to Connor Centner, Ph.D., ULSOM Class of 2027, for receiving the KYNETIC grant! His research in histotripsy technology is set to transform cancer treatment. UofL is proud to support this innovative work!

Read more: https://t.co/EASBeHJqm3

[Connor S. Centner, Ph.D. @ConnorCentner]

Exciting progress in #CancerTreatment! Focused ultrasound (histotripsy) is being developed to target colon & lung cancers with a new device small enough for endoscopes. Precision, speed, and hope for the future. Read more: https://t.co/UXJ9reYir8

[Connor S. Centner, Ph.D. @ConnorCentner]

Thrilled to announce I’ve been awarded the KYNETIC grant as Principal Investigator to further develop histotripsy for cancer treatment. Huge thanks to @KYNETIC_hub and @uoflmedschool for the support! https://t.co/cU6nFGnaiE

[Nicole Robertson MD, MPH @Dr_Robertson_MD]

In our new #Lupus article we review literature and report the first case of treatment of discoid lupus with lenalidomide and anifrolumab with robust improvement. A combinational approach has great potential in discoid lupus➡️https://t.co/gfHFKmlhGq
@ConnorCentner @jhrheumatology

[Connor S. Centner, Ph.D. @ConnorCentner]

Centner et al., Biomodulatory Effects of Molecular Delivery in Human T Cells Using 3D-Printed Acoustofluidic Devices. Ultrasound in Medicine and Biology (2024) https://t.co/9w8KwJ8y7Z

[Connor S. Centner, Ph.D. @ConnorCentner]

Our recent publication highlights the bioeffects of ultrasound on cellular and subcellular structures! Using an advanced device, we observed changes that could impact cell-based therapies. (see thread for link) #Ultrasound #Biophysics #CellTherapy